NO914429L - Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister - Google Patents
Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonisterInfo
- Publication number
- NO914429L NO914429L NO91914429A NO914429A NO914429L NO 914429 L NO914429 L NO 914429L NO 91914429 A NO91914429 A NO 91914429A NO 914429 A NO914429 A NO 914429A NO 914429 L NO914429 L NO 914429L
- Authority
- NO
- Norway
- Prior art keywords
- campersulphonyloxytocin
- piperidinyl
- antagonists
- procedure
- preparation
- Prior art date
Links
- -1 PIPERIDINYL Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61234490A | 1990-11-13 | 1990-11-13 | |
| US75925491A | 1991-09-13 | 1991-09-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO914429D0 NO914429D0 (no) | 1991-11-12 |
| NO914429L true NO914429L (no) | 1992-05-14 |
Family
ID=27086744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91914429A NO914429L (no) | 1990-11-13 | 1991-11-12 | Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0486280A3 (de) |
| JP (1) | JPH0751564B2 (de) |
| KR (1) | KR920009822A (de) |
| AU (1) | AU8780191A (de) |
| CA (1) | CA2055024A1 (de) |
| FI (1) | FI915329A (de) |
| IE (1) | IE913933A1 (de) |
| IL (1) | IL99957A0 (de) |
| MX (1) | MX9102028A (de) |
| NO (1) | NO914429L (de) |
| PT (1) | PT99483A (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648352A (en) * | 1991-09-13 | 1997-07-15 | Merck & Co., Inc. | Piperazinylcamphorsulfonyl oxytocin antagonists |
| CZ56194A3 (en) * | 1991-09-13 | 1995-06-14 | Merck & Co Inc | Derivatives of piperazinyl(sulfonyl) amide of camphor as oxytocin antagonists |
| EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| US5693643A (en) * | 1991-09-16 | 1997-12-02 | Merck & Co., Inc. | Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| EP0533243B1 (de) * | 1991-09-16 | 1997-12-17 | Merck & Co. Inc. | Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten |
| EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| EP0533241A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| JPH08502474A (ja) * | 1992-10-07 | 1996-03-19 | メルク エンド カンパニー インコーポレーテッド | トコリティックオキシトシンレセプターアンタゴニスト |
| CA2118756A1 (en) * | 1993-03-12 | 1994-09-13 | Anthony M. Demarco | Process for the synthesis of substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| JPH09500134A (ja) * | 1993-07-16 | 1997-01-07 | メルク エンド カンパニー インコーポレーテッド | ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤 |
| EP0708765A4 (de) * | 1993-07-16 | 1996-06-26 | Merck & Co Inc | Substituierte piperazinylkampher-derivate als oxytoxin-antagonisten |
| US5670509A (en) * | 1993-09-27 | 1997-09-23 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| WO1995014025A1 (en) * | 1993-11-16 | 1995-05-26 | Merck & Co., Inc. | Piperidinylcamphorsulfonyl oxytocin antagonists |
| US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| US5656606A (en) * | 1995-02-17 | 1997-08-12 | Merck & Co., Inc. | Camphor compounds promote release of growth hormone |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0103710D0 (sv) | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
| SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| MX2007002033A (es) | 2004-08-19 | 2007-04-26 | Vertex Pharma | Moduladores de receptores muscarinicos. |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| AU2005309365B2 (en) | 2004-11-29 | 2011-10-06 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| WO2007076070A2 (en) | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| RU2008137593A (ru) | 2006-02-22 | 2010-03-27 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецепторов |
| AU2007221220A1 (en) | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Spiro condensed piperidnes as modulators of muscarinic receptors |
| US7858790B2 (en) | 2006-06-29 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| WO2008021375A2 (en) | 2006-08-15 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2660974A1 (en) | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| JP2010540640A (ja) | 2007-10-03 | 2010-12-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン作用性レセプターのモジュレーター |
| RU2649406C1 (ru) * | 2017-09-21 | 2018-04-03 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | 3-n-замещенные борнилпропионаты, используемые в качестве ингибиторов вируса марбург |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3666764A (en) * | 1970-08-26 | 1972-05-30 | Mead Johnson & Co | Spiroindenylpiperidines |
| US3654287A (en) * | 1970-08-26 | 1972-04-04 | Mead Johnson & Co | Spiroindanylpiperidines |
| EP0450761A1 (de) * | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Spirocyclische Oxtocin-Antagonisten |
-
1991
- 1991-11-05 IL IL99957A patent/IL99957A0/xx unknown
- 1991-11-06 CA CA002055024A patent/CA2055024A1/en not_active Abandoned
- 1991-11-12 MX MX9102028A patent/MX9102028A/es unknown
- 1991-11-12 IE IE393391A patent/IE913933A1/en not_active Application Discontinuation
- 1991-11-12 NO NO91914429A patent/NO914429L/no unknown
- 1991-11-12 FI FI915329A patent/FI915329A/fi not_active Application Discontinuation
- 1991-11-12 PT PT99483A patent/PT99483A/pt not_active Application Discontinuation
- 1991-11-12 AU AU87801/91A patent/AU8780191A/en not_active Abandoned
- 1991-11-13 KR KR1019910020099A patent/KR920009822A/ko not_active Application Discontinuation
- 1991-11-13 EP EP19910310476 patent/EP0486280A3/en not_active Withdrawn
- 1991-11-13 JP JP3352632A patent/JPH0751564B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI915329A (fi) | 1992-05-14 |
| AU8780191A (en) | 1992-05-14 |
| JPH0532634A (ja) | 1993-02-09 |
| IE913933A1 (en) | 1992-05-20 |
| IL99957A0 (en) | 1992-08-18 |
| PT99483A (pt) | 1992-09-30 |
| EP0486280A3 (en) | 1992-12-09 |
| MX9102028A (es) | 1994-05-31 |
| EP0486280A2 (de) | 1992-05-20 |
| CA2055024A1 (en) | 1992-05-14 |
| FI915329A0 (fi) | 1991-11-12 |
| NO914429D0 (no) | 1991-11-12 |
| KR920009822A (ko) | 1992-06-25 |
| JPH0751564B2 (ja) | 1995-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO914429L (no) | Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister | |
| NO905255L (no) | Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler. | |
| NO921777L (no) | Fremgangsmaate for fremstilling av isoparaffiner | |
| NO914027L (no) | Fremgangsmaate for fremstilling av nye substituerte azetidinoner | |
| NO905008L (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser. | |
| NO912346L (no) | Fremgangsmaate for fremstilling av aminobenzodiazepiner. | |
| NO911122D0 (no) | Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler. | |
| NO924885D0 (no) | Fremgangsmaate for fremstilling av syntesegass | |
| NO904285D0 (no) | Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner. | |
| NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
| NO920049D0 (no) | Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere | |
| NO914053L (no) | Fremgangsmaate for fremstilling av 8-klorokinolonderivater | |
| NO920938D0 (no) | Fremgangsmaate til fremstilling av oksamid | |
| NO168594C (no) | Fremgangsmaate for bygging av hengebro | |
| NO914985L (no) | Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater | |
| NO904060D0 (no) | Fremgangsmaate for fremstilling av substituerte dibenzofuraner. | |
| NO933262D0 (no) | Fremgangsmaate for fremstilling av alkosymagnesiumhalogenider | |
| NO922709D0 (no) | Fremgangsmaate for fremstilling av vanadium-bis-arener | |
| NO914452D0 (no) | Fremgangsmaate for fremstilling av isokinolinderivater | |
| NO904588D0 (no) | Fremgangsmaate til fremstilling av diazinylpiperidin-derivater | |
| NO914586D0 (no) | Fremgangsmaate for fremstilling av polyeterester | |
| NO911665D0 (no) | Fremgangsmaate for fremstilling av nye nojirimycinderivater | |
| NO930481D0 (no) | Fremgangsmaate for fremstilling av klormetaner | |
| IT9019885A0 (it) | Procedimento di preparazione di nuove tieno-triazolo-diazepine | |
| NO914560L (no) | Fremgangsmaate for fremstilling av fiberformig magnesiumoksid |